BlackRock Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $232K | Buy |
2,789
+785
| +39% | +$65.3K | ﹤0.01% | 2608 |
|
|
2016
Q3 | $224K | Buy |
2,004
+81
| +4% | +$9.05K | ﹤0.01% | 2580 |
|
|
2016
Q2 | $213K | Buy |
1,923
+84
| +5% | +$9.3K | ﹤0.01% | 2552 |
|
|
2016
Q1 | $192K | Buy |
1,839
+764
| +71% | +$79.8K | ﹤0.01% | 2572 |
|
|
2015
Q4 | $86K | Sell |
1,075
-35
| -3% | -$2.8K | ﹤0.01% | 2720 |
|
|
2015
Q3 | $77K | Buy |
1,110
+283
| +34% | +$19.6K | ﹤0.01% | 2751 |
|
|
2015
Q2 | $81K | Buy |
827
+223
| +37% | +$21.8K | ﹤0.01% | 2784 |
|
|
2015
Q1 | $59K | Buy |
604
+214
| +55% | +$20.9K | ﹤0.01% | 2739 |
|
|
2014
Q4 | $43K | Buy |
+390
| New | +$43K | ﹤0.01% | 2787 |
|
|
2014
Q3 | – | Sell |
-11,657
| Closed | -$1.51M | – | 2830 |
|
|
2014
Q2 | $1.51M | Buy |
11,657
+7,363
| +171% | +$955K | ﹤0.01% | 1585 |
|
|
2014
Q1 | $686K | Buy |
+4,294
| New | +$686K | ﹤0.01% | 2111 |
|